Preemptive administration of mesenchymal stem cells-derived conditioned medium can attenuate the development of neuropathic pain in rats via downregulation of proinflammatory cytokines
Behavioural Brain Research · 2024
DOI: 10.1016/j.bbr.2024.114858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2024. Verfasst von Samad Nazemi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, School of Medical Sciences, Sabzevar University of Medical Sciences, Sabzevar, Iran; Cellular and Molecula…. Hauptthemen laut MEDLINE: Neuralgia, Mesenchymal Stem Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Sabzevar University of Medical Sciences.
Abstract (Originalsprache)
Neuropathic pain (NP) is a chronic condition characterized by persistent pain following nerve injury. It is a challenging clinical problem to manage due to limited treatment options. Mesenchymal stem cells (MSCs)-derived conditioned medium (CM) is a cell-free product that contains the secretome of MSCs and has been shown to have therapeutic potential in various inflammatory and degenerative disorders. Several animal studies have examined the antinociceptive effects of MSCs-CM on established neuropathic pain, but none have investigated the early prevention of neuropathic pain using MSCs-CM. Therefore, in this study, we tested whether preemptive administration of MSCs-CM could attenuate the development of NP in rats. To this end, NP was induced in Wistar rats using a chronic constriction injury (CCI) model (day 0), and then the animals were divided into four groups: Sham, CCI, CCI-Dulbecco's Modified Eagle Medium (DMEM), and CCI-CM. The CCI-CM group received 1 ml intraperitoneal administration of MSCs-CM on days - 1, 1, and 2, while the Sham, CCI, and CCI-DMEM groups received vehicle only (normal saline or DMEM). Mechanical withdrawal threshold and thermal withdrawal latency were assessed to evaluate pain sensitivities. In addition, the expression levels of proinflammatory cytokines (TNF-α and IL-1β) in the spinal cord tissues were measured using quantitative real-time PCR (qRT-PCR). The results demonstrated that preemptive treatment with MSCs-CM can significantly attenuate the development of NP, as evidenced by improved mechanical withdrawal threshold and thermal withdrawal latency in the CCI-CM group compared to the CCI and CCI-DMEM groups. Furthermore, the relative gene expression of proinflammatory cytokines TNF-α and IL-1β were significantly decreased in the spinal cord tissues of the CCI-CM group compared to the control groups. These findings suggest that preemptive administration of MSCs-CM can attenuate the development of NP in rats, partly due to the downregulation of proinflammatory cytokines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pharmacology, School of Medical Sciences, Sabzevar University of Medical Sciences, Sabzevar, Iran; Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar,…
- Student Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran.
- Department of Physiology and Pharmacology, School of Medical Sciences, Sabzevar University of Medical Sciences, Sabzevar, Iran.
- Department of Immunology, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran. Electronic address: mojadadi@gmail.com.
Förderung
- Sabzevar University of Medical Sciences
Zitieren
APA
Nazemi, S., Helmi, M., Kafami, M., Amin, B., & Mojadadi, M. S. (2024). Preemptive administration of mesenchymal stem cells-derived conditioned medium can attenuate the development of neuropathic pain in rats via downregulation of proinflammatory cytokines. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2024.114858
Vancouver
Nazemi S, Helmi M, Kafami M, Amin B, Mojadadi MS. Preemptive administration of mesenchymal stem cells-derived conditioned medium can attenuate the development of neuropathic pain in rats via downregulation of proinflammatory cytokines. Behavioural Brain Research. 2024. doi:10.1016/j.bbr.2024.114858
BibTeX
@article{Nazemi2024,
author = {Nazemi, Samad and Helmi, Mahtab and Kafami, Marzieh and Amin, Bahareh and Mojadadi, Mohammad-Shafi},
title = {Preemptive administration of mesenchymal stem cells-derived conditioned medium can attenuate the development of neuropathic pain in rats via downregulation of proinflammatory cytokines},
journal = {Behavioural Brain Research},
year = {2024},
doi = {10.1016/j.bbr.2024.114858}
}
EUVIMED